To Identify Potential New Urine Marker Panel for Cancer Screening
Recruiting now
Conditions studied: Cancer
In brief
Polyamines are naturally produced metabolites in our cells. There were some reports suggested the urinary levels of polyamines were altered in patients with different cancers. This study is to explore the use of urinary polyamine for the diagnosis of common cancers.
Key facts
- Study ID
- NCT04689802
- Run by
- Chinese University of Hong Kong
- People needed
- 2500
- Starts
- 2021-01-20
- Expected to finish
- 2026-03-31
- Last updated by the study team
- 2025-05-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients with age > 18 years old.
- For cancer patients, a histological diagnosis of cancer is available.
- For normal control, there is no diagnosis of cancer in the medical record.
You may not qualify if…
- Patient with recent urinary tract infection within 6 weeks prior to urine collection.
- Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to urine collection.
- Patient refused or unable to provide consent for the study
Where it is running
- Prince of Wales Hospital — Shatin, Hong Kong (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.